Determination of Dimethylamine in Metformin HCl Drug Product Using IC with Suppressed Conductivity Detection

Significance of the Topic

Metformin is one of the most prescribed treatments for type 2 diabetes and is synthesized from dimethylamine hydrochloride and 2-cyanoguanidine. Residual dimethylamine in the final product can lead to formation of nitrosamines, which are potential carcinogens. Monitoring trace levels of dimethylamine ensures product safety and consistency in pharmaceutical manufacturing.

Study Objectives and Overview

The primary aim was to develop and validate an ion chromatography method with suppressed conductivity detection to accurately quantify residual dimethylamine in metformin hydrochloride drug products. The study evaluates sensitivity, specificity, and reproducibility of the method under typical pharmaceutical quality control conditions.

Methodology and Instrumentation

Sample preparation involved grinding metformin tablets, dissolving in deionized water, and filtration. Standards of dimethylamine hydrochloride were prepared at concentrations ranging from 0.01 to 2.0 mg/L to establish calibration curves and detection limits.

Instrumentation used

• Thermo Scientific Dionex ICS-2000 Reagent-Free IC System
• Dionex IonPac CS19 Analytical Column (4 × 250 mm) with CG19 Guard Column (4 × 50 mm)
• Dionex EGC III Methanesulfonic Acid EluGen Cartridge with CR-CTC II Trap Column
• Suppressed conductivity detection using Dionex CSRS™ 300 Suppressor

The eluent was generated in situ at controlled gradients of methanesulfonic acid (2–40 mM). Chromatographic conditions included a flow rate of 1.0 mL/min, 40 °C column temperature, and a 20 µL injection volume.

Results and Discussion

The method achieved baseline separation of dimethylamine from six common cations (Li⁺, Na⁺, NH₄⁺, K⁺, Mg²⁺, Ca²⁺). The method detection limit (MDL) was determined to be 1.5 µg/L based on replicate injections, with a signal-to-noise ratio confirming sensitivity. Calibration was linear across the tested range (0.1–2.0 mg/L) with high correlation when forced through the origin.

Analysis of metformin samples showed an average dimethylamine concentration of 0.482 mg/L (0.0482% w/w relative to tablet mass). Spike recovery experiments at 0.1 mg/L yielded 101% recovery, demonstrating accuracy and absence of matrix interference.

Benefits and Practical Applications

This suppressed conductivity IC method provides superior sensitivity compared to nonsuppressed techniques and offers robust quantitation of trace amine impurities in pharmaceutical products. It is readily implementable in QA/QC laboratories for routine release testing and stability monitoring.

Future Trends and Potential Applications

• Integration of automated sample preparation and online dilution systems to increase throughput.
• Application to a broader range of residual amines and related impurities in diverse drug formulations.
• Combination with mass spectrometric detection for structural confirmation and multi-target analysis.
• Adoption of greener chromatographic practices through minimized solvent consumption and waste.

Conclusion

The developed ion chromatography method with suppressed conductivity detection is sensitive, accurate, and reproducible for determining trace dimethylamine in metformin hydrochloride. It supports stringent pharmaceutical quality standards and enhances safety monitoring of potential nitrosamine precursors.

Reference

1. Metformin, Wikipedia, Wikimedia Foundation, accessed Feb. 14, 2012.
2. n-Nitroso-Dimethylamine CAS #62-75-9 Fact Sheet, ATSDR, CDC, July 1999.
3. U.S. Pharmacopeia 34 NF 29 Metformin Hydrochloride monograph, 2011.
4. Application Note 199 N-Methylpyrrolidine in Cefepime, Dionex, 2008.
5. Application Note 259 N-Methylpyrrolidine in Cefepime with Nonsuppressed Detection, Dionex, 2010.
6. Application Note 284 Ethyl Sulfate Impurity in Indinavir Sulfate, Dionex, 2011.
7. Application Note 262 2-Ethylhexanoic Acid Impurity in Clavulanate, Dionex, 2010.